Richon Pharmaceuticals Private Limited
About Richon Pharmaceuticals Private Limited
Data last updated:
Richon Pharmaceuticals Private Limited is a private limited company based in Raipur, Chhattisgarh, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 07 June 2023.
The company is registered with the Registrar of Companies (ROC), Chhattisgarh, under CIN U21001CT2023PTC014770.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors Vansh Agrawal and Honey Agrawal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Raipur, Chhattisgarh.
As per the financials filed for FY 2025, the company reported a revenue of ₹66,590. For the same year it recorded a net loss of ₹34.11 Lakh and EBITDA of -₹33.99 Lakh.
As per MCA filings, the company has open charges of ₹8.71 Cr on record.
Company details
Contact details
Richon Pharmaceuticals Private Limited's registered office is in Raipur, Chhattisgarh.
- Registered AddressBlock – B – 602, Crosswinds, Raipur, Chhattisgarh, India – 492004
- IndustryPharma, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Richon Pharmaceuticals Private Limited
FY 2025 filings availableRichon Pharmaceuticals Private Limited reported revenue of ₹66,590 for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹33.99 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹34.11 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Richon Pharmaceuticals Private Limited, buy the company report.
Board of directors of Richon Pharmaceuticals Private Limited
Richon Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vansh Agrawal Also directs: Sarala Foods Private Limited, Saralafoods Impex Private Limited, Chilika Impex Limited and 1 more | Director | 07 Dec 2024 | 1 Years 10 Months | Current |
| Honey Agrawal Also directs: Sarala Foods Private Limited, Grain Edge Processing Private Limited, Saralafoods Impex Private Limited and 2 more | Nominee Director | 07 Dec 2024 | 1 Years 10 Months | Current |
Peer comparison
Richon Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mediclay Pharmaceuticals Private Limited | ₹67,123 (FY 2024) | 126.0% | Delhi, India | |||
| Gastro Pharmaceuticals India Private Limited | ₹66,985 (FY 2025) | -85.0% | Chennai, Tamil Nadu, India | |||
| Globacare Private Limited | ₹66,965 (FY 2025) | -97.0% | New Delhi, Delhi, India | |||
| Genuinecare India Pharmaceuticals Private Limited | ₹66,927 (FY 2022) | Mauja, Uttar Pradesh, India | ||||
| Siddhaquest Pharmaceuticals Private Limited | ₹66,682 (FY 2021) | Chennai, Tamil Nadu, India | ||||
| Richon Pharmaceuticals Private Limitedthis company | ₹66,590 (FY 2025) | -₹34.11 Lakh | Raipur, Chhattisgarh, India | |||
| Truvida Pharmaceuticals Private Limited | ₹66,451 (FY 2024) | Hyderabad, Telangana, India | ||||
| Prarthana Pharmaceuticals Private Limited | ₹66,013 (FY 2025) | -93.0% | Gaya, Bihar, India | |||
| Aarudhra Pharmaceuticals Private Limited | ₹66,000 (FY 2022) | Tirupur, Tamil Nadu, India | ||||
| South Fork Ranch Private Limited | ₹65,890 (FY 2025) | -4.0% | New Delhi, Delhi, India | |||
| Nervet Pharmaceuticals Private Limited | ₹65,820 (FY 2024) | Haridwar, Uttarakhand, India |
To see the full peer comparison of Richon Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Mar 2025 | 101081761 | Others | ₹4.36 Cr | Open | |
| 28 Mar 2025 | 101081961 | Others | ₹4.36 Cr | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Richon Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Richon Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Richon Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Richon Pharmaceuticals Private Limited has 6 board changes on record since 2023: 4 appointments and 2 cessations. The latest: Moulika Satthi ceased to be Director on 13 Dec 2024.
Frequently asked questions
Richon Pharmaceuticals is an active private limited company based in Raipur, Chhattisgarh, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 07 June 2023 (3+ years old) and is registered under CIN U21001CT2023PTC014770.
Richon Pharmaceuticals has 2 current directors:
- Vansh Agrawal - Director
- Honey Agrawal - Nominee Director
The latest financial statements of Richon Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Richon Pharmaceuticals is U21001CT2023PTC014770. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Richon Pharmaceuticals was incorporated on 07 June 2023, making it 3+ years old. It is registered with the Registrar of Companies, Chhattisgarh.
The peers of Richon Pharmaceuticals by revenue are Mediclay Pharmaceuticals Private Limited, Gastro Pharmaceuticals India Private Limited, Globacare Private Limited, Genuinecare India Pharmaceuticals Private Limited, Siddhaquest Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Moulika Satthi ceased to be Director on 13 Dec 2024. Shubham Goyal ceased to be Director on 13 Dec 2024. Honey Agrawal was appointed as Nominee Director on 07 Dec 2024. Richon Pharmaceuticals has 6 board changes on record in total.
The registered office of Richon Pharmaceuticals is at Block – B – 602, Crosswinds, Raipur, Chhattisgarh, India – 492004.
Richon Pharmaceuticals operates in the pharma industry, in the api manufacturers segment.
Richon Pharmaceuticals has open charges of ₹8.71 Cr and no satisfied charges on record as per latest MCA filings.
Richon Pharmaceuticals can be reached at its registered office: Block – B – 602, Crosswinds, Raipur, Chhattisgarh, India – 492004.